Cardiac Failure Review (CFR) is a review journal aimed at assisting heart failure specialists and cardiologists to stay abreast of key advances and opinion in the diagnosis, management and treatment of heart failure. CFR provides comprehensive reviews on a range of pertinent issues to support physicians in continuously developing their knowledge and effectiveness in day-to-day clinical practice.
Led by Editor-in-Chief Andrew Coats, and underpinned by an editorial board of world-renowned physicians, CFR is comprised of peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field of heart failure.
For information on submitting an article, please contact the Managing Editor, Rosie Scott: email@example.com
Frequency: Three print issues per year (Spring, Summer, Autumn); ePub ahead of print throughout the year.
Print ISSN: 2057-7540
Online ISSN: 2057-7559
Aims and Scope
CFR aims to assist time-pressured physicians to stay abreast of key advances and opinion in heart failure. The journal comprises balanced and comprehensive articles written by leading authorities, addressing the most pertinent developments in the field.
CFR provides comprehensive updates on a range of issues to support physicians in continuously developing their knowledge and effectiveness in day-to-day clinical practice.
Structure and Format
CFR is a tri-annual journal, comprising review articles, expert opinion articles and guest editorials.
The structure and degree of coverage assigned to each category of the journal is the decision of the Editor-in-Chief, with the support of the Editorial Board.
CFR is guided by overall direction from an Editor-in-Chief, supported by the Editorial Board comprising leading authorities from a variety of related disciplines.
The journal’s contributors are recognised authorities in their respective fields.
Peer review is conducted by experts appointed for their experience and knowledge of a specific topic.
CFR is produced by an experienced team of Editors and Technical Editors.
On submission, all articles are assessed by the Editor-in-Chief to determine their suitability for inclusion.
The Managing Editor, following consultation with the Editor-in-Chief sends the manuscript to reviewers who are selected on the basis of their specialist knowledge in the relevant area. All peer review is conducted double-blind.
Following review, manuscripts are accepted without modification, accepted pending modification (in which case the manuscripts are returned to the author(s) to incorporate required changes), or rejected outright. The Editor-in-Chief reserves the right to accept or reject any proposed amendments.
Once the authors have amended a manuscript in accordance with the reviewers’ comments, the manuscript is assessed to ensure the revised version meets quality expectations. The manuscript is sent to the Editor-in-Chief for final approval prior to publication.
Submissions and Instructions to Authors
Contributors are identified by the Editor-in-Chief with the support of the Editorial Board and Managing Editor.
Following acceptance of an invitation, the author(s) and Managing Editor, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article.
Our funding model
At this moment, Radcliffe Cardiology provides free educational content to cardiologists and allied healthcare professionals. The vast majority of our content is editorially independent, developed at our own cost.
However, to keep the platform a free resource, from time-to-time we do collaborate and receive funding from select industry partners in the following ways and all sources of such funding are fully declared on all these materials:
- Print and eBook adverts at the front and back of the journals (never within the journal text).
- Web banner advertising.
- Interstitial adverts.
- Pre-roll video adverts (as pre-cursors to our independent content).
- Promotional/supplemental content (published as supplements to our peer-reviewed journals).
- Supported webinars, roundtable discussions, video interviews and live cases.
- Continuing medical education (CME) activities.
To support open access publication costs, Radcliffe Cardiology charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows: £1050 UK | €1200 Eurozone | $1369 all other countries.
(Submissions from the UK will be subject to the current UK VAT charge. A VAT registration number should be supplied to ensure any invoice accounts for VAT at your local relevant rate. Those not registered for VAT will have VAT added).
APC Waivers and Discounts
A 100% waiver is available for all papers which are solicited directly from Radcliffe Cardiology.
Authors from low-income countries as defined by the World Bank are eligible for a full waiver of the APC charge. Authors from middle-income countries are eligible for a 50% waiver. Discretionary waivers may also be considered.
Radcliffe Cardiology remains dedicated to helping researchers to disseminate scientific information globally and is actively working to partner with individual institutions to offer full or partial APC discounts. Institutional agreements will be listed here. If you are an institution looking to partner with us, or think your institution should, then please contact the Publishing Director.
To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors. Authors should submit a waiver request during the electronic submission process.
All articles included in CFR are available as reprints (minimum order 1,000). Please contact Rob Barclay at firstname.lastname@example.org
Distribution and Readership
CFR is distributed through controlled circulation to senior healthcare professionals in Europe.
Abstracting and Indexing
Copyright and Permission
Radcliffe Cardiology is the sole owner of all articles and other materials that appear in Cardiac Failure Review unless otherwise stated. Permission to reproduce an article, either in full or in part, should be sought from the publication’s Managing Editor.